Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Urinary Kallidinogenase in Acute Cerebral Infarction
NCT02259738Phase 2Completed
- Start
- Jan 2013
- Primary completion
- Jun 2014
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Human urinary kallidinogenase in ischemic stroke. Primary endpoint: Perfusion Weighted Imaging at 7 days. Started Jan 2013; status: completed.
02
Drugs
Human urinary kallidinogenase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02259738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259738.